Ossama Eissa MBA Cellares

Chief Operating Officer, Cellares joined Cellares in November 2024 as Chief Operating Officer, bringing over two decades of leadership in biopharma manufacturing, to scale the company globally and meet rapidly rising demand for automated cell therapy manufacturing. Prior Experience & Contributions: - Legend Biotech (VP & General Manager): Led the Raritan, NJ production site through the global launch of Carvykti®, a FDA-approved CAR‑T therapy—a first-of-its-kind commercial-scale operation. - Novartis: Oversaw U.S. manufacturing operations, scaling production and supporting regulatory approval for Kymriah®, the first FDA-approved CAR‑T therapy. - Lonza Biologics: Directed Global Strategic Projects and significantly scaled manufacturing efficiency within the Cell & Gene Technologies BU. Cellares